XGN — Exagen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Exagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	57.4	99.4	62.4	36.5	22
Net Total Accounts Receivable
Net Total Receivables	8.91	9.65	6.08	6.55	7.83
Prepaid Expenses
Total Current Assets	70.5	113	72.6	47.8	36.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.1	4.77	13.1	8.49	7.68
Net Goodwill
Other Long Term Assets
Total Assets	78.4	123	86.2	56.9	44.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.77	9.32	9.62	11.9	13.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	36.5	38.5	43.8	34.3	35.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	41.8	84.9	42.5	22.7	9.54
Total Liabilities & Shareholders' Equity	78.4	123	86.2	56.9	44.7
Total Common Shares Outstanding